Terms: = Breast cancer AND Ki-67 AND Prognosis
923 results:
1. Impact of Pregnancy on breast cancer Features and prognosis.
Bounous VE; Minella C; Fuso L; Actis S; Petroni G; Sgrò LG; Borghese M; Tomasi Cont N; Ponzone R; Ferrero A
Curr Oncol; 2024 Apr; 31(4):2305-2315. PubMed ID: 38668074
[TBL] [Abstract] [Full Text] [Related]
2. Effect of tumor-infiltrating immune cells (mast cells, neutrophils and lymphocytes) on neoadjuvant chemotherapy response in breast carcinomas.
Okcu O; Öztürk Ç; Yalçın N; Yalçın AC; Şen B; Aydın E; Öztürk AE
Ann Diagn Pathol; 2024 Jun; 70():152301. PubMed ID: 38581761
[TBL] [Abstract] [Full Text] [Related]
3. Case report: A case of Paget disease outside the axillary breast.
Zhou Z; Zhou B; Wu X; Wei W
Medicine (Baltimore); 2024 Mar; 103(13):e37541. PubMed ID: 38552095
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
[TBL] [Abstract] [Full Text] [Related]
5. Accuracy of cytological grading in the carcinoma breast and its correlation with pathological prognostic parameters.
Chauhan D; Sahu N; Sahoo SR; Senapati U
J Cancer Res Ther; 2023 Oct; 19(7):1956-1961. PubMed ID: 38376303
[TBL] [Abstract] [Full Text] [Related]
6. ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in breast cancer.
Yang ZG; Ren LH; Wang F; Wang PL; Wang WY; Lin SY
Curr Med Sci; 2024 Feb; 44(1):156-167. PubMed ID: 38302780
[TBL] [Abstract] [Full Text] [Related]
7. Solid basal adenoid cystic carcinoma of the breast: A case report and literature review.
Gou WB; Yang YQ; Song BW; He P
Medicine (Baltimore); 2024 Jan; 103(3):e37010. PubMed ID: 38241532
[TBL] [Abstract] [Full Text] [Related]
8. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer.
Wang W; Lei W; Fang Z; Jiang R; Wang X
BMC Cancer; 2024 Jan; 24(1):1. PubMed ID: 38166784
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy.
Shao Y; Guan H; Luo Z; Yu Y; He Y; Chen Q; Liu C; Zhu F; Liu H
Breast; 2024 Feb; 73():103666. PubMed ID: 38159433
[TBL] [Abstract] [Full Text] [Related]
11. Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for ki-67 in breast cancer.
Arora R; Alam F; Zaka-Ur-Rab A; Maheshwari V; Alam K; Hasan M
J Egypt Natl Canc Inst; 2023 Dec; 35(1):43. PubMed ID: 38143264
[TBL] [Abstract] [Full Text] [Related]
12. Validation of CTS5 Model in Large-scale breast cancer Population and Combination of CTS5 and ki-67 Status to Develop a Novel Nomogram for prognosis Prediction.
Ning L; Liu Y; He X; Han R; Xin Y; Zhao J; Liu X
Am J Clin Oncol; 2024 May; 47(5):228-238. PubMed ID: 38131531
[TBL] [Abstract] [Full Text] [Related]
13. [The expression of Plakoglobin in residual cancer after neoadjuvant chemotherapy for breast cancer and its prognostic impact on patients].
Li Y; Guo L; Guo CY; Lei CQ; Zhang K; Wang NC; Wang ZZ; Xuan LX
Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1057-1064. PubMed ID: 38110314
[No Abstract] [Full Text] [Related]
14. The Clinicopathological Features and Prognostic Significance of HER2-Low in Early breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative breast cancer Stratified by Hormone Receptor Status.
Gamrani S; Akhouayri L; Boukansa S; Karkouri M; El Fatemi H
Breast J; 2023; 2023():6621409. PubMed ID: 38075551
[TBL] [Abstract] [Full Text] [Related]
15. Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with ki-67-positive expression in non-mass enhancement of breast cancer.
Nie T; Feng M; Yang K; Guo X; Yuan Z; Zhang Z; Yan G
Sci Rep; 2023 Dec; 13(1):21451. PubMed ID: 38052920
[TBL] [Abstract] [Full Text] [Related]
16. [Evaluation of the predictive effect of PD-L1 expression on survival in early triple-negative breast cancer].
Yue J; Wang X; Zhu AJ; Wang DY; Gao SL; Hu NL; Si YR; Zheng FC; Ju J; Wang Z; Yuan P
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):948-954. PubMed ID: 37968080
[No Abstract] [Full Text] [Related]
17. Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution.
Chen D; Wang Q; Dong M; Chen F; Huang A; Chen C; Lu Y; Zhao W; Wang L
BMC Cancer; 2023 Oct; 23(1):984. PubMed ID: 37845617
[TBL] [Abstract] [Full Text] [Related]
18. Correlation between conventional ultrasound features combined with contrast-enhanced ultrasound patterns and pathological prognostic factors in malignant non-mass breast lesions.
Wang T; Guo W; Zhang X; Ma J; Li F; Zheng S; Zhu M; Dong Y; Bai M
Clin Hemorheol Microcirc; 2023; 85(4):433-445. PubMed ID: 37781796
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological and prognostic value of TIL and PD L1 in triple negative breast carcinomas.
Uğurluoğlu C; Yormaz S
Pathol Res Pract; 2023 Oct; 250():154828. PubMed ID: 37778126
[TBL] [Abstract] [Full Text] [Related]
20. The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer.
Zohair B; Chraa D; Rezouki I; Benthami H; Razzouki I; Elkarroumi M; Olive D; Karkouri M; Badou A
Front Immunol; 2023; 14():1201632. PubMed ID: 37753093
[TBL] [Abstract] [Full Text] [Related]
[Next]
